社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
K_j
IP属地：海外
+关注
帖子 · 4
帖子 · 4
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
K_j
K_j
·
2021-12-28
Wow
非常抱歉，此主贴已删除
看
2,604
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
K_j
K_j
·
2021-12-28
Ohhh
Apple Allegedly Preparing for iPhones Without SIM Card Slot by September 2022<blockquote>据称苹果准备在2022年9月之前推出不带SIM卡插槽的iPhone</blockquote>
Earlier this week, a rumor from Brazilian website Blog do iPhone claimed that iPhone 15 Pro models m
Apple Allegedly Preparing for iPhones Without SIM Card Slot by September 2022<blockquote>据称苹果准备在2022年9月之前推出不带SIM卡插槽的iPhone</blockquote>
看
2,151
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
K_j
K_j
·
2021-05-06
👍👍👍
This COVID-19 Vaccine Stock Quietly Soared 75% In April: Is There More Upside Ahead?<blockquote>这只COVID-19疫苗股在4月份悄然飙升75%：未来还有更多上涨空间吗？</blockquote>
Shares ofBioNTech SE, which partnered withPfizer Inc. in successfully developing a vaccine against t
This COVID-19 Vaccine Stock Quietly Soared 75% In April: Is There More Upside Ahead?<blockquote>这只COVID-19疫苗股在4月份悄然飙升75%：未来还有更多上涨空间吗？</blockquote>
看
1,202
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
K_j
K_j
·
2021-05-06
👍👍👍
This COVID-19 Vaccine Stock Quietly Soared 75% In April: Is There More Upside Ahead?<blockquote>这只COVID-19疫苗股在4月份悄然飙升75%：未来还有更多上涨空间吗？</blockquote>
Shares ofBioNTech SE, which partnered withPfizer Inc. in successfully developing a vaccine against t
This COVID-19 Vaccine Stock Quietly Soared 75% In April: Is There More Upside Ahead?<blockquote>这只COVID-19疫苗股在4月份悄然飙升75%：未来还有更多上涨空间吗？</blockquote>
看
1,795
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3583246291910733","uuid":"3583246291910733","gmtCreate":1620153627549,"gmtModify":1620153627549,"name":"K_j","pinyin":"kjkj","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":6,"tweetSize":4,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.06.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"海外","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":696120452,"gmtCreate":1640651883921,"gmtModify":1640651884040,"author":{"id":"3583246291910733","authorId":"3583246291910733","name":"K_j","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583246291910733","idStr":"3583246291910733"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696120452","repostId":"1133233035","repostType":4,"isVote":1,"tweetType":1,"viewCount":2604,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696120145,"gmtCreate":1640651839570,"gmtModify":1640651839570,"author":{"id":"3583246291910733","authorId":"3583246291910733","name":"K_j","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583246291910733","idStr":"3583246291910733"},"themes":[],"htmlText":"Ohhh","listText":"Ohhh","text":"Ohhh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696120145","repostId":"1128219386","repostType":4,"repost":{"id":"1128219386","kind":"news","pubTimestamp":1640606013,"share":"https://www.laohu8.com/m/news/1128219386?lang=zh_CN&edition=full","pubTime":"2021-12-27 19:53","market":"us","language":"en","title":"Apple Allegedly Preparing for iPhones Without SIM Card Slot by September 2022<blockquote>据称苹果准备在2022年9月之前推出不带SIM卡插槽的iPhone</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1128219386","media":"MacRumors","summary":"Earlier this week, a rumor from Brazilian website Blog do iPhone claimed that iPhone 15 Pro models m","content":"<p>Earlier this week, a rumor from Brazilian website <i>Blog do iPhone</i> claimed that iPhone 15 Pro models might not have a physical SIM card slot in at least some countries and regions, but the change might happen even sooner.</p><p><blockquote>本周早些时候，一则来自巴西网站的传言<i>iPhone博客</i>声称iPhone 15 Pro机型可能至少在一些国家和地区没有物理SIM卡插槽，但这种变化可能会更快发生。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/50051c321b0f16ef0e8d00f767c8e0c1\" tg-width=\"800\" tg-height=\"450\" width=\"100%\" height=\"auto\"><span>Image: iFixit</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片：iFixit</span></p></blockquote></p><p> An anonymous tipster informed<i>MacRumors</i>that Apple has advised major U.S. carriers to prepare for the launch of eSIM-only smartphones by September 2022. The tipster shared a seemingly legitimate document outlining the timeframe for this initiative, although the document does not specifically mention Apple or the iPhone.</p><p><blockquote>一位匿名线人告知<i>MacRumors</i>苹果已建议美国主要运营商准备在2022年9月之前推出纯eSIM智能手机。线人分享了一份看似合法的文件，概述了这一举措的时间表，尽管该文件没有具体提到苹果或iPhone。</blockquote></p><p> As part of the transition, some U.S. carriers will allegedly start offering select iPhone 13 models without a nano-SIM card in the box in the second quarter of 2022. iPhone 13 models sold at Apple Stores or on Apple.com already lack a nano-SIM card in the box, with users typically able to activate a cellular plan via eSIM by turning on the iPhone, connecting to a Wi-Fi network, and following the on-screen instructions.</p><p><blockquote>作为过渡的一部分，据称一些美国运营商将在2022年第二季度开始提供包装盒中没有nano-SIM卡的精选iPhone 13机型。在苹果商店或Apple.com上销售的iPhone 13型号的包装盒中已经没有nano-SIM卡，用户通常可以通过打开iPhone、连接到Wi-Fi网络并按照屏幕上的说明通过eSIM激活蜂窝计划。</blockquote></p><p> Given the alleged September 2022 deadline, it is possible that Apple might remove the physical SIM card slot starting with some iPhone 14 models, rather than some iPhone 15 models as originally rumored, but nothing is definitive at this point.</p><p><blockquote>鉴于所谓的2022年9月截止日期，苹果可能会从一些iPhone 14机型开始取消物理SIM卡插槽，而不是最初传言的一些iPhone 15机型，但目前还没有确定的结果。</blockquote></p><p> An eSIM is a digital SIM that allows users to activate a cellular plan without having to use a nano-SIM card. It's worth noting that eSIM service is not available in all countries, so iPhones with a SIM card slot may remain available in some markets. Adoption is expanding rapidly, though, with over 100 carriers offering eSIM service worldwide and more planning to roll out support in 2022, including Three in the UK and Vodafone in New Zealand.</p><p><blockquote>eSIM是一种数字SIM卡，允许用户在不使用nano-SIM卡的情况下激活蜂窝计划。值得注意的是，eSIM服务并非在所有国家都可用，因此带有SIM卡插槽的iPhone可能仍会在某些市场提供。不过，采用率正在迅速扩大，全球有100多家运营商提供eSIM服务，更多运营商计划在2022年推出支持，包括英国的三家和新西兰的沃达丰。</blockquote></p><p> iPhone 13 models already support multiple eSIM profiles, allowing users to subscribe to several cellular plans digitally and switch between them, and this functionality could pave the way for the SIM card slot's removal in select countries.</p><p><blockquote>iPhone 13机型已经支持多个eSIM配置文件，允许用户以数字方式订阅多个蜂窝计划并在它们之间切换，这一功能可能为在特定国家/地区取消SIM卡插槽铺平道路。</blockquote></p><p> Apple's former design chief Jony Ive once envisioned the iPhone as becoming a \"single slab of glass,\" and the SIM card slot's removal would be another step towards a seamless design and improve water resistance in the process. Taking out the slot would also free up some valuable internal space in the iPhone — every bit counts.</p><p><blockquote>苹果前设计主管Jony Ive曾设想iPhone将成为“一块单板玻璃”，移除SIM卡插槽将是迈向无缝设计的又一步，并在此过程中提高防水性。取出插槽还可以释放iPhone中一些宝贵的内部空间——每一点都很重要。</blockquote></p><p></p>","source":"lsy1637734094842","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Allegedly Preparing for iPhones Without SIM Card Slot by September 2022<blockquote>据称苹果准备在2022年9月之前推出不带SIM卡插槽的iPhone</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Allegedly Preparing for iPhones Without SIM Card Slot by September 2022<blockquote>据称苹果准备在2022年9月之前推出不带SIM卡插槽的iPhone</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">MacRumors</strong><span class=\"h-time small\">2021-12-27 19:53</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Earlier this week, a rumor from Brazilian website <i>Blog do iPhone</i> claimed that iPhone 15 Pro models might not have a physical SIM card slot in at least some countries and regions, but the change might happen even sooner.</p><p><blockquote>本周早些时候，一则来自巴西网站的传言<i>iPhone博客</i>声称iPhone 15 Pro机型可能至少在一些国家和地区没有物理SIM卡插槽，但这种变化可能会更快发生。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/50051c321b0f16ef0e8d00f767c8e0c1\" tg-width=\"800\" tg-height=\"450\" width=\"100%\" height=\"auto\"><span>Image: iFixit</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片：iFixit</span></p></blockquote></p><p> An anonymous tipster informed<i>MacRumors</i>that Apple has advised major U.S. carriers to prepare for the launch of eSIM-only smartphones by September 2022. The tipster shared a seemingly legitimate document outlining the timeframe for this initiative, although the document does not specifically mention Apple or the iPhone.</p><p><blockquote>一位匿名线人告知<i>MacRumors</i>苹果已建议美国主要运营商准备在2022年9月之前推出纯eSIM智能手机。线人分享了一份看似合法的文件，概述了这一举措的时间表，尽管该文件没有具体提到苹果或iPhone。</blockquote></p><p> As part of the transition, some U.S. carriers will allegedly start offering select iPhone 13 models without a nano-SIM card in the box in the second quarter of 2022. iPhone 13 models sold at Apple Stores or on Apple.com already lack a nano-SIM card in the box, with users typically able to activate a cellular plan via eSIM by turning on the iPhone, connecting to a Wi-Fi network, and following the on-screen instructions.</p><p><blockquote>作为过渡的一部分，据称一些美国运营商将在2022年第二季度开始提供包装盒中没有nano-SIM卡的精选iPhone 13机型。在苹果商店或Apple.com上销售的iPhone 13型号的包装盒中已经没有nano-SIM卡，用户通常可以通过打开iPhone、连接到Wi-Fi网络并按照屏幕上的说明通过eSIM激活蜂窝计划。</blockquote></p><p> Given the alleged September 2022 deadline, it is possible that Apple might remove the physical SIM card slot starting with some iPhone 14 models, rather than some iPhone 15 models as originally rumored, but nothing is definitive at this point.</p><p><blockquote>鉴于所谓的2022年9月截止日期，苹果可能会从一些iPhone 14机型开始取消物理SIM卡插槽，而不是最初传言的一些iPhone 15机型，但目前还没有确定的结果。</blockquote></p><p> An eSIM is a digital SIM that allows users to activate a cellular plan without having to use a nano-SIM card. It's worth noting that eSIM service is not available in all countries, so iPhones with a SIM card slot may remain available in some markets. Adoption is expanding rapidly, though, with over 100 carriers offering eSIM service worldwide and more planning to roll out support in 2022, including Three in the UK and Vodafone in New Zealand.</p><p><blockquote>eSIM是一种数字SIM卡，允许用户在不使用nano-SIM卡的情况下激活蜂窝计划。值得注意的是，eSIM服务并非在所有国家都可用，因此带有SIM卡插槽的iPhone可能仍会在某些市场提供。不过，采用率正在迅速扩大，全球有100多家运营商提供eSIM服务，更多运营商计划在2022年推出支持，包括英国的三家和新西兰的沃达丰。</blockquote></p><p> iPhone 13 models already support multiple eSIM profiles, allowing users to subscribe to several cellular plans digitally and switch between them, and this functionality could pave the way for the SIM card slot's removal in select countries.</p><p><blockquote>iPhone 13机型已经支持多个eSIM配置文件，允许用户以数字方式订阅多个蜂窝计划并在它们之间切换，这一功能可能为在特定国家/地区取消SIM卡插槽铺平道路。</blockquote></p><p> Apple's former design chief Jony Ive once envisioned the iPhone as becoming a \"single slab of glass,\" and the SIM card slot's removal would be another step towards a seamless design and improve water resistance in the process. Taking out the slot would also free up some valuable internal space in the iPhone — every bit counts.</p><p><blockquote>苹果前设计主管Jony Ive曾设想iPhone将成为“一块单板玻璃”，移除SIM卡插槽将是迈向无缝设计的又一步，并在此过程中提高防水性。取出插槽还可以释放iPhone中一些宝贵的内部空间——每一点都很重要。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.macrumors.com/2021/12/26/iphones-without-sim-card-slot-2022-rumor/\">MacRumors</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.macrumors.com/2021/12/26/iphones-without-sim-card-slot-2022-rumor/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128219386","content_text":"Earlier this week, a rumor from Brazilian website Blog do iPhone claimed that iPhone 15 Pro models might not have a physical SIM card slot in at least some countries and regions, but the change might happen even sooner.\nImage: iFixit\nAn anonymous tipster informedMacRumorsthat Apple has advised major U.S. carriers to prepare for the launch of eSIM-only smartphones by September 2022. The tipster shared a seemingly legitimate document outlining the timeframe for this initiative, although the document does not specifically mention Apple or the iPhone.\nAs part of the transition, some U.S. carriers will allegedly start offering select iPhone 13 models without a nano-SIM card in the box in the second quarter of 2022. iPhone 13 models sold at Apple Stores or on Apple.com already lack a nano-SIM card in the box, with users typically able to activate a cellular plan via eSIM by turning on the iPhone, connecting to a Wi-Fi network, and following the on-screen instructions.\nGiven the alleged September 2022 deadline, it is possible that Apple might remove the physical SIM card slot starting with some iPhone 14 models, rather than some iPhone 15 models as originally rumored, but nothing is definitive at this point.\nAn eSIM is a digital SIM that allows users to activate a cellular plan without having to use a nano-SIM card. It's worth noting that eSIM service is not available in all countries, so iPhones with a SIM card slot may remain available in some markets. Adoption is expanding rapidly, though, with over 100 carriers offering eSIM service worldwide and more planning to roll out support in 2022, including Three in the UK and Vodafone in New Zealand.\niPhone 13 models already support multiple eSIM profiles, allowing users to subscribe to several cellular plans digitally and switch between them, and this functionality could pave the way for the SIM card slot's removal in select countries.\nApple's former design chief Jony Ive once envisioned the iPhone as becoming a \"single slab of glass,\" and the SIM card slot's removal would be another step towards a seamless design and improve water resistance in the process. Taking out the slot would also free up some valuable internal space in the iPhone — every bit counts.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":2151,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":102461837,"gmtCreate":1620231897729,"gmtModify":1634206785556,"author":{"id":"3583246291910733","authorId":"3583246291910733","name":"K_j","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583246291910733","idStr":"3583246291910733"},"themes":[],"htmlText":"👍👍👍","listText":"👍👍👍","text":"👍👍👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/102461837","repostId":"1131387668","repostType":4,"repost":{"id":"1131387668","kind":"news","pubTimestamp":1620228331,"share":"https://www.laohu8.com/m/news/1131387668?lang=zh_CN&edition=full","pubTime":"2021-05-05 23:25","market":"us","language":"en","title":"This COVID-19 Vaccine Stock Quietly Soared 75% In April: Is There More Upside Ahead?<blockquote>这只COVID-19疫苗股在4月份悄然飙升75%：未来还有更多上涨空间吗？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1131387668","media":"benzinga","summary":"Shares ofBioNTech SE, which partnered withPfizer Inc. in successfully developing a vaccine against t","content":"<p><div> Shares ofBioNTech SE, which partnered withPfizer Inc. in successfully developing a vaccine against the coronavirus, have been gaining ground. BioNTech's Price Action:BioNTech and its partner ...</p><p><blockquote><div>BioNTech SE与辉瑞公司合作成功开发了针对冠状病毒的疫苗，其股价一直在上涨。BioNTech的价格走势：BioNTech及其合作伙伴...</div></blockquote></p><p> <a href=\"https://www.benzinga.com/general/biotech/21/05/20918917/this-covid-19-vaccine-stock-quietly-soared-75-in-april-is-there-more-upside-ahead\">网页链接</a> </div> </p><p><blockquote><a href=\"https://www.benzinga.com/general/biotech/21/05/20918917/this-covid-19-vaccine-stock-quietly-soared-75-in-april-is-there-more-upside-ahead\">网页连接</a></blockquote></p><p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This COVID-19 Vaccine Stock Quietly Soared 75% In April: Is There More Upside Ahead?<blockquote>这只COVID-19疫苗股在4月份悄然飙升75%：未来还有更多上涨空间吗？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis COVID-19 Vaccine Stock Quietly Soared 75% In April: Is There More Upside Ahead?<blockquote>这只COVID-19疫苗股在4月份悄然飙升75%：未来还有更多上涨空间吗？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">benzinga</strong><span class=\"h-time small\">2021-05-05 23:25</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Shares ofBioNTech SE, which partnered withPfizer Inc. in successfully developing a vaccine against the coronavirus, have been gaining ground. BioNTech's Price Action:BioNTech and its partner ...</p><p><blockquote><div>BioNTech SE与辉瑞公司合作成功开发了针对冠状病毒的疫苗，其股价一直在上涨。BioNTech的价格走势：BioNTech及其合作伙伴...</div></blockquote></p><p> <a href=\"https://www.benzinga.com/general/biotech/21/05/20918917/this-covid-19-vaccine-stock-quietly-soared-75-in-april-is-there-more-upside-ahead\">网页链接</a> </div> </p><p><blockquote><a href=\"https://www.benzinga.com/general/biotech/21/05/20918917/this-covid-19-vaccine-stock-quietly-soared-75-in-april-is-there-more-upside-ahead\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.benzinga.com/general/biotech/21/05/20918917/this-covid-19-vaccine-stock-quietly-soared-75-in-april-is-there-more-upside-ahead\">benzinga</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE"},"source_url":"https://www.benzinga.com/general/biotech/21/05/20918917/this-covid-19-vaccine-stock-quietly-soared-75-in-april-is-there-more-upside-ahead","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131387668","content_text":"Shares ofBioNTech SE, which partnered withPfizer Inc. in successfully developing a vaccine against the coronavirus, have been gaining ground.\nBioNTech's Price Action:BioNTech and its partner Pfizerreceived in mid-Decemberauthorization for emergency use of the BNT162b2 mRNA vaccine against the novel coronavirus that causes COVID-19.\nBioNTech's shares, which rallied to a high of $131 ahead of the FDA decision, gave back part of the gains in a ‘buy-the-rumor, sell-the-news' move. The stock ended 2020 at $81.52, about 38% off the intraday high for the year.\nThe German vaccine maker's stock picked up momentum early in 2021, breaching the $100 psychological resistance level on Jan. 8 and trading in a $100-$120 range until early March.\nThe marketwide selloff in March did not spare BioNTech, with the stock dropping below $100 for a few sessions before climbing back again. The stock was locked in a lackluster phase until the end of March.\nCome April, the trend began to change. In the very first session of April, the stock rose over 4% and moved steadily higher through the month. In April alone, the stock added 72.4%.\nTo put things in perspective, if an investor had invested $1,000 in BioNTech shares at the end of March, their investment would now be worth $1,909.46 (using the intraday high of $207.55 hit on Monday). This would mean nearly doubling the investment in a span of a month.\nWhat's Behind The BioNTech Rally:The stock has been supported by the intermittent news flow regarding the company's vaccine.\nIn late March, the companies reported positive top-line results from a study evaluating the vaccine in adolescents.\nOn April 1, BioNTech and Pfizer reported data on BNT162b2 following six months of follow-up that confirmed its efficacy and safety.\nThe companies announced April 9 a request to the FDA to authorize expanded use of the vaccine in adolescents ages 12-15.\nThe FDA'sdecisionto temporarily pause the use ofJohnson & Johnson'sJNJ 0.2%vaccine also proved positive for BioNTech, which added about 7% on April 13 when the pause was announced.\nIn mid-April, the companies announced an agreement with the European Union to supply 100 million doses of BNT162b2, which is named Comirnaty in Europe, in 2021. With that, the total number of doses delivered to the EU is 600 million.\nLast week, a request was submitted to the EU to expand conditional marketing authorization to adolescents in the EU.\nWhat Lies Ahead For BioNTech Stock?BNT162b2 is expected to continue to boost BioNTech's top-line. Having delivered 200 million doses by the end of March, the company has signed orders for supplying 1.4 billion doses in 2021.\nPfizer and BioNTech plan to boost the manufacturing capacity for the vaccine to 2.5 billion doses by the end of 2021.\n\"BioNTech and Pfizer will be the standout leader in COVID-19 vaccination globally, with demand increasing for the 2.5Bn doses they are targeting to manufacture in 2021,\" SVB Leerink analyst Daina Graybosch said in a note.\nWith the second wave of the COVID-19 pandemic now sweeping across several nations, the companies have a lucrative opportunity. The companies have also proved the efficacy of the vaccine against variants.\nOnce the pandemic phase passes, the vaccine has scope for use in endemic setting.\nMore importantly, BioNTech is not a one-trick pony. The company has a broad oncology pipeline consisting of 13 product candidates.\nWeighing in all the opportunities, further upside in the stock cannot be ruled out.\nBNTX Price Action:At last check, BioNTech shares were rising 8.2% to $191.38.","news_type":1,"symbols_score_info":{"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":1202,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":102463726,"gmtCreate":1620231844365,"gmtModify":1634206785676,"author":{"id":"3583246291910733","authorId":"3583246291910733","name":"K_j","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3583246291910733","idStr":"3583246291910733"},"themes":[],"htmlText":"👍👍👍","listText":"👍👍👍","text":"👍👍👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/102463726","repostId":"1131387668","repostType":4,"repost":{"id":"1131387668","kind":"news","pubTimestamp":1620228331,"share":"https://www.laohu8.com/m/news/1131387668?lang=zh_CN&edition=full","pubTime":"2021-05-05 23:25","market":"us","language":"en","title":"This COVID-19 Vaccine Stock Quietly Soared 75% In April: Is There More Upside Ahead?<blockquote>这只COVID-19疫苗股在4月份悄然飙升75%：未来还有更多上涨空间吗？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1131387668","media":"benzinga","summary":"Shares ofBioNTech SE, which partnered withPfizer Inc. in successfully developing a vaccine against t","content":"<p><div> Shares ofBioNTech SE, which partnered withPfizer Inc. in successfully developing a vaccine against the coronavirus, have been gaining ground. BioNTech's Price Action:BioNTech and its partner ...</p><p><blockquote><div>BioNTech SE与辉瑞公司合作成功开发了针对冠状病毒的疫苗，其股价一直在上涨。BioNTech的价格走势：BioNTech及其合作伙伴...</div></blockquote></p><p> <a href=\"https://www.benzinga.com/general/biotech/21/05/20918917/this-covid-19-vaccine-stock-quietly-soared-75-in-april-is-there-more-upside-ahead\">网页链接</a> </div> </p><p><blockquote><a href=\"https://www.benzinga.com/general/biotech/21/05/20918917/this-covid-19-vaccine-stock-quietly-soared-75-in-april-is-there-more-upside-ahead\">网页连接</a></blockquote></p><p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This COVID-19 Vaccine Stock Quietly Soared 75% In April: Is There More Upside Ahead?<blockquote>这只COVID-19疫苗股在4月份悄然飙升75%：未来还有更多上涨空间吗？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis COVID-19 Vaccine Stock Quietly Soared 75% In April: Is There More Upside Ahead?<blockquote>这只COVID-19疫苗股在4月份悄然飙升75%：未来还有更多上涨空间吗？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">benzinga</strong><span class=\"h-time small\">2021-05-05 23:25</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Shares ofBioNTech SE, which partnered withPfizer Inc. in successfully developing a vaccine against the coronavirus, have been gaining ground. BioNTech's Price Action:BioNTech and its partner ...</p><p><blockquote><div>BioNTech SE与辉瑞公司合作成功开发了针对冠状病毒的疫苗，其股价一直在上涨。BioNTech的价格走势：BioNTech及其合作伙伴...</div></blockquote></p><p> <a href=\"https://www.benzinga.com/general/biotech/21/05/20918917/this-covid-19-vaccine-stock-quietly-soared-75-in-april-is-there-more-upside-ahead\">网页链接</a> </div> </p><p><blockquote><a href=\"https://www.benzinga.com/general/biotech/21/05/20918917/this-covid-19-vaccine-stock-quietly-soared-75-in-april-is-there-more-upside-ahead\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.benzinga.com/general/biotech/21/05/20918917/this-covid-19-vaccine-stock-quietly-soared-75-in-april-is-there-more-upside-ahead\">benzinga</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE"},"source_url":"https://www.benzinga.com/general/biotech/21/05/20918917/this-covid-19-vaccine-stock-quietly-soared-75-in-april-is-there-more-upside-ahead","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131387668","content_text":"Shares ofBioNTech SE, which partnered withPfizer Inc. in successfully developing a vaccine against the coronavirus, have been gaining ground.\nBioNTech's Price Action:BioNTech and its partner Pfizerreceived in mid-Decemberauthorization for emergency use of the BNT162b2 mRNA vaccine against the novel coronavirus that causes COVID-19.\nBioNTech's shares, which rallied to a high of $131 ahead of the FDA decision, gave back part of the gains in a ‘buy-the-rumor, sell-the-news' move. The stock ended 2020 at $81.52, about 38% off the intraday high for the year.\nThe German vaccine maker's stock picked up momentum early in 2021, breaching the $100 psychological resistance level on Jan. 8 and trading in a $100-$120 range until early March.\nThe marketwide selloff in March did not spare BioNTech, with the stock dropping below $100 for a few sessions before climbing back again. The stock was locked in a lackluster phase until the end of March.\nCome April, the trend began to change. In the very first session of April, the stock rose over 4% and moved steadily higher through the month. In April alone, the stock added 72.4%.\nTo put things in perspective, if an investor had invested $1,000 in BioNTech shares at the end of March, their investment would now be worth $1,909.46 (using the intraday high of $207.55 hit on Monday). This would mean nearly doubling the investment in a span of a month.\nWhat's Behind The BioNTech Rally:The stock has been supported by the intermittent news flow regarding the company's vaccine.\nIn late March, the companies reported positive top-line results from a study evaluating the vaccine in adolescents.\nOn April 1, BioNTech and Pfizer reported data on BNT162b2 following six months of follow-up that confirmed its efficacy and safety.\nThe companies announced April 9 a request to the FDA to authorize expanded use of the vaccine in adolescents ages 12-15.\nThe FDA'sdecisionto temporarily pause the use ofJohnson & Johnson'sJNJ 0.2%vaccine also proved positive for BioNTech, which added about 7% on April 13 when the pause was announced.\nIn mid-April, the companies announced an agreement with the European Union to supply 100 million doses of BNT162b2, which is named Comirnaty in Europe, in 2021. With that, the total number of doses delivered to the EU is 600 million.\nLast week, a request was submitted to the EU to expand conditional marketing authorization to adolescents in the EU.\nWhat Lies Ahead For BioNTech Stock?BNT162b2 is expected to continue to boost BioNTech's top-line. Having delivered 200 million doses by the end of March, the company has signed orders for supplying 1.4 billion doses in 2021.\nPfizer and BioNTech plan to boost the manufacturing capacity for the vaccine to 2.5 billion doses by the end of 2021.\n\"BioNTech and Pfizer will be the standout leader in COVID-19 vaccination globally, with demand increasing for the 2.5Bn doses they are targeting to manufacture in 2021,\" SVB Leerink analyst Daina Graybosch said in a note.\nWith the second wave of the COVID-19 pandemic now sweeping across several nations, the companies have a lucrative opportunity. The companies have also proved the efficacy of the vaccine against variants.\nOnce the pandemic phase passes, the vaccine has scope for use in endemic setting.\nMore importantly, BioNTech is not a one-trick pony. The company has a broad oncology pipeline consisting of 13 product candidates.\nWeighing in all the opportunities, further upside in the stock cannot be ruled out.\nBNTX Price Action:At last check, BioNTech shares were rising 8.2% to $191.38.","news_type":1,"symbols_score_info":{"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":1795,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}